MedPath

Adolescent and Young Adult Cancer Survivors: Identity Development

Active, not recruiting
Conditions
Cancer
Registration Number
NCT00832325
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to better understand how the illness has affected the identity and what needs the survivor may have. We hope that this information will help us provide better care to future adolescent and young adult cancer survivors.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Current age greater than and including 15 and up to and including 25 years of age at time of consent
  • Diagnosis of a first cancer > or = to 14 and up to and including 21 years of age
  • At least 6 months post-treatment according to participant's self-report.
  • Able to provide informed consent (or parent or legal guardian consent and participant assent for those participants under 18 years of age)
  • Able to speak English. This inclusion criterion is included because study assessments were designed and validated in English and many of them are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the assessments.
Exclusion Criteria
  • Will exclude survivors with severe cognitive impairment that precludes them from being able to give information consent and/or complete the questionnaires.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conduct a comprehensive qualitative assessment through individual interviews and focus groups of identity development, peer and family relationships, and psychosocial concerns among survivors diagnosed during adolescence.3 years
Secondary Outcome Measures
NameTimeMethod
Conduct a prospective longitudinal assessment of identity development and peer and family relationships among survivors diagnosed during adolescence.3 years

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.